Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | IGFBP3 | P17936 | 2/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 8/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 8/20 | 0.40 |
| ▸ | TTR | P02766 | 2/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23228767 | 0.90 | PARP10 (0.44) | MAPK1IGFBP3MAPT | |
| SCHEMBL23228792 | 0.89 | ALDH1A1 (0.44) | LMNAMAPK1IGFBP3MAPT | |
| SCHEMBL21656973 | 0.88 | HDAC1 (0.42) | MAPT | |
| SCHEMBL23228809 | 0.88 | SLC6A2 (0.46) | IGFBP3LPAR1LPAR5MAPT | |
| SCHEMBL23228785 | 0.88 | CA12 (0.37) | LMNAMAPK1IGFBP3MAPT | |
| SCHEMBL23228800 | 0.88 | SLC6A2 (0.44) | MAPK1HTTS1PR2MAPT | |
| SCHEMBL21656871 | 0.88 | RAB9A (0.44) | RAB9ALMNAMAPK1HTTNPC1 | |
| SCHEMBL21656878 | 0.82 | PTGER4 (0.41) | RAB9ALMNANPC1POLBCYP2C9 | |
| SCHEMBL20953498 | 0.81 | MAPT (0.40) | RAB9ALMNAMAPK1NPC1MAPT | |
| SCHEMBL21628475 | 0.81 | RAB9A (0.63) | RAB9ALMNAMAPK1HTTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | RAB9A 2955/4885LMNA 3327/4885MAPK1 3508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.